BioCentury | Dec 12, 2020
Product Development

Ipsen is casting a wider BD net under new CEO Loew

...its best-selling drug, Somatuline, faces generic competition.The somatostatin...
BioCentury | Jun 27, 2020
Regulation

Boxed warning on Zogenix’s Dravet syndrome therapy could hamper market prospects

...excess growth hormone and IGF-1 production. The company said Mycapssa is the only approved oral SST...
...2020 low of $2.98 on March 18. Targets IGF-1 - Insulin-like growth factor-1 SST - Somatostatin...
...RG3806, octreolin) Fintepla, fenfluramine oral solution (ZX008, brabafen) abicipar pegol (AGN-150998, MP0112) Chiasma Inc. Zogenix Inc. AbbVie Inc. Allergan plc Molecular Partners AG Somatostatin (SST) Vascular...
BioCentury | Apr 1, 2020
Finance

March 31 Quick Takes: Cowen leads €47M addition to AM-Pharma's C round; plus Zucara, CellFe, Zentalis and Shanghai Junshi

...patients with Type I diabetes; the funds will also support Phase II testing (see "Suppressing Somatostatin"...
...Commission (CSRC). Junshi dropped HK$2.35 to HK$28.95 in Hong Kong on Tuesday. Targets SSTR2 - Somatostatin...
BioCentury | Jan 29, 2020
Company News

Launches fuel Novartis’ growth as CEO reiterates China commitment

...We still believe that this has blockbuster potential,” Schaffert said. Lutathera is approved to treat somatostatin...
BioCentury | Jan 11, 2020
Finance

Why buysiders say 2020 could be the year of the CNS

...Peroxisome proliferation activated receptor alpha PPARδ - Peroxisome proliferation activated receptor delta SSTR2 - Somatostatin...
BioCentury | Jul 23, 2019
Clinical News

July 23 Clinical Quick Takes: Achillion plans U.S. IND; plus Chiasma, Myovant, Marinus and Merck

...Chiasma Inc. (NASDAQ:CHMA) climbed $1.66 (27%) to $7.86 Tuesday after reporting an oral formulation of somatostatin...
...in the Phase III CHIASMA OPTIMAL trial for adults with acromegaly previously controlled by injectable somatostatin...
BioCentury | May 28, 2019
Company News

Months after scuttling IPO bid, Centrexion adds to balance sheet with Lilly deal for pain therapy

...Nerve growth factor; PACAP38 - Pituitary adenylate cyclase activating polypeptide-38 isoform; SSTR4 - Small molecule somatostatin...
...TRPV1 (VR1) - Transient receptor potential vanilloid 1 Mark Zipkin, Staff Writer CNTX-0290 Centrexion Therapeutics Corp. Eli Lilly and Co. Somatostatin...
BioCentury | Feb 21, 2019
Clinical News

Partial hold for Phase I of Xencor's blood cancer bispecific

...bispecific antibodies: XmAb13676 and XmAb18087. XmAb13676 targets CD3 and CD20, and XmAb18087 targets CD3 and somatostatin...
BioCentury | Feb 20, 2019
Clinical News

Partial hold for Phase I of Xencor's blood cancer bispecific

...after Bispecific Antibody Deal with Novartis" ). Targets: CD123 - IL-3 receptor α; SSTR2 - Somatostatin...
BioCentury | Jan 5, 2019
Finance

Longitude takes a spin with Cydan

...Agarwala told BioCentury the mechanism of action that tripped up BIM-23A760 in acromegaly gives the dopamine-somatostatin...
...said BIM-23A760 showed strong dopaminergic activity, but weak evidence of somatostatinergic activity. NFPAs express both somatostatin...
...was central to TBR-760's de-risking because it's designed to show clear clinical benefit. A second dopamine-somatostatin...
Items per page:
1 - 10 of 333